60 Day FRN - published

Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Utilizing a Targeted Media Campaign
and Community Health Workers to
Increase Breast and Cervical Cancer
Screening Among Muslim Women, SIP
15–004.’’
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, [email protected].
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–09084 Filed 4–20–15; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–15ZT; Docket No. CDC–2015–
0023]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites

tkelley on DSK3SPTVN1PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:07 Apr 20, 2015

Jkt 235001

comment on the proposed information
collection request for the Performance
Measurement and Program Evaluation
of the Autism and Developmental
Disabilities Monitoring Network
(ADDM). CDC seeks to collect
performance monitoring and program
evaluation data from all sites
participating in the ADDM network.
DATES: Written comments must be
received on or before June 22, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0023 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE.,
MS–D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
Comments are invited on: (a) Whether
the proposed collection of information
FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

22195

is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Performance Measurement and
Program Evaluation of the Autism and
Developmental Disabilities Monitoring
Network (ADDM)—New—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC) is a new Information
Collection Request.
Background and Brief Description
In January 2015, CDC launched a new
phase of funding for its autism spectrum
disorder (ASD) surveillance program
through a new cooperative agreement:
‘‘Enhancing Public Health Surveillance
of Autism Spectrum Disorder and Other
Developmental Disabilities through the
Autism and Developmental Disabilities
Monitoring (ADDM) Network’’ under
the Funding Opportunity
Announcement (FOA) DD15–1501.
Through this cooperative agreement,
funding is provided to enhance tracking
at eight existing sites and to launch two
new sites. Awards were made to state/
local health departments and/or their
designated representatives, including
Colorado Department of Public Health
and Environment, Johns Hopkins
University, Rutgers University,
University of Arizona, University of

E:\FR\FM\21APN1.SGM

21APN1

22196

Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices

Arkansas for Medical Sciences,
University of North Carolina at Chapel
Hill, University of Minnesota,
University of Wisconsin-Madison,
Vanderbilt University, and Washington
University in St. Louis. Four sites
received funding to carry out
Component A, which focuses on
surveillance of ASD and either cerebral
palsy or intellectual disability among 8year-olds. Six sites received funding to
carry out both Component A as well as
Component B, which focuses on
surveillance of ASD among 4-year-olds.
In addition to the sites funded under the
cooperative agreement, CDC also
administers a site in Atlanta, Georgia,
commonly known as the Metropolitan
Atlanta Developmental Disabilities
Surveillance Program (MADDSP).
CDC requests OMB approval to collect
performance monitoring and program
evaluation information from all sites
participating in the Autism and

Developmental Disabilities Monitoring
Network (including the site
administered by CDC). Over the course
of the four-year funding cycle, each site
will submit a Checklist, Worksheets,
and Performance Measures every six
month and two-year intervals. The
Checklist, Worksheets, and Performance
Measures will be submitted to CDC by
completing a Microsoft Excel-based data
collection tool and uploading the
information to a secure, passwordprotected FTP site. By developing a
user-friendly data collection tool in
Microsoft Excel, CDC anticipates that
the reporting and tracking burden for
awardees will be reduced due to: (1)
awardees’ familiarity with the software,
which reduces training burden; and (2)
the compatibility of the templates with
other record keeping processes that are
already in place for many awardees.
CDC staff and contractors will be
responsible for converting each

awardee’s submissions into a secure
Microsoft Access-based system for
reporting and analysis. CDC anticipates
that respondent burden will be slightly
higher at the initial six-month
submission and will also be slightly
higher for sites completing Component
A&B compared to just Component A.
The information to be collected will
help CDC and awardees assure
compliance with cooperative agreement
requirements, support program
evaluation efforts, and obtain
information needed to respond to
inquiries about program activities and
program impact from Congress and
other stakeholders.
OMB approval is requested for three
years. Participation is required as a
condition of cooperative agreement
funding. There are no costs to
respondents other than their time. The
total estimated burden hours are 125.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
hours

Form name

Component A only (initial six-month
submission).

Checklist ...........................................

5

1

3/60

1

Worksheets ......................................
Performance Measures ....................
Checklist ...........................................

5
5
6

1
1
1

1.5
30/60
3/60

8
3
1

Worksheets ......................................
Performance Measures ....................
Checklist ...........................................

6
6
5

1
1
5

2
4/60
3/60

12
4
1

Worksheets ......................................
Performance Measures ....................
Checklist ...........................................

5
5
6

5
5
5

1
18/60
3/60

25
8
2

Worksheets ......................................
Performance Measures ....................

6
6

5
5

1.5
30/60

45
15

Component A&B (initial six-month
submission).
Component A only (subsequent sixmonth and two-year submissions).
Component A&B (subsequent sixmonth and two-year submissions).

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–09087 Filed 4–20–15; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES

Number
responses per
respondent

Number of
respondents

Type of respondents

Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Effectiveness of Teen

VerDate Sep<11>2014

19:23 Apr 20, 2015

Jkt 235001

Pregnancy Prevention Program Designed
specifically for Young Males, DP15–007,
initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on April 14, 2015 Volume 80,
Number 71, pages 19989. The title of the
Special Emphasis Panel should read as
above and time and date should read as
follows:
TIME AND DATE: 9:00 a.m.–6:00 p.m.,
April 7–8, 2015 (Closed).
FOR FURTHER INFORMATION CONTACT: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated

PO 00000

Frm 00035

Fmt 4703

Sfmt 4703

the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–09083 Filed 4–20–15; 8:45 am]
BILLING CODE 4163–18–P

E:\FR\FM\21APN1.SGM

21APN1